Active	Status	Sponsor type	Region	Phase	Filter
15 Active 16 Inactive 31 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

15 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gusenoff, Jeffrey
PopSole2, NCT04378270: Validation of a Novel Foot Offloading Device	Completed	N/A	20	US	PopSole™ Offloading Device	Jeffrey A. Gusenoff, MD	Plantar Fasciitis, Chronic, Heel Pain Syndrome, Fat Pad Syndrome	10/21	10/21
Simon, Patsy
NCT04601532: Superficial Partial-Thickness Burn Study	Terminated	4	26	US	Catasyn™ Advanced Technology Hydrogel and SynePure™ Wound Cleanser, Silver Sulfadiazine, Silvadene Topical Product	J. Peter Rubin, MD, Synedgen, Inc., United States Department of Defense	Superficial Partial Thickness Burn	12/22	12/22
NCT05343143: NeuraGen 3D Pilot Study	Terminated	N/A	1	US	NeuraGen 3D Nerve Guide Matrix	Integra LifeSciences Corporation	Digital Nerve Injury	07/23	05/24
NCT05482425: Autologous Facial Fat Grafting Study	Active, not recruiting	N/A	26	US	Autologous facial fat graft injection	University of Pittsburgh	Facial Skin Texture, Facial Skin Pigmentation	09/25	01/26
NCT06747715: Autologous Fresh Fat Grafting Followed by Autologous Cryopreserved Fat Grafting	Not yet recruiting	N/A	22	US	Serial Fat Grafting Fresh followed by Cryopreserved Fat	University of Pittsburgh, Armed Forces Institute of Regenerative Medicine	Facial Defect	12/27	12/27
Rubin, J Peter
NCT04601532: Superficial Partial-Thickness Burn Study	Terminated	4	26	US	Catasyn™ Advanced Technology Hydrogel and SynePure™ Wound Cleanser, Silver Sulfadiazine, Silvadene Topical Product	J. Peter Rubin, MD, Synedgen, Inc., United States Department of Defense	Superficial Partial Thickness Burn	12/22	12/22
NCT03880656: BM-MNCs for Lower Extremity Compartment Syndrome Injury	Active, not recruiting	1	18	US	Intramuscular administration of autologous BM-MNCs	Oregon Health and Science University	Compartment Syndrome Traumatic Lower Extremity	12/25	06/26
NCT04051242: Enhanced Bioscaffold for Volumetric Muscle Loss	Terminated	N/A	10	US	XenMatrix™ AB Surgical Graft	J. Peter Rubin, MD, United States Department of Defense	Muscle Loss	01/24	01/24
NCT04440189: Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis	Recruiting	N/A	124	US	GID SVF-2 Device System	GID BIO, Inc.	Osteoarthritis, Knee	12/23	12/24
NCT05482425: Autologous Facial Fat Grafting Study	Active, not recruiting	N/A	26	US	Autologous facial fat graft injection	University of Pittsburgh	Facial Skin Texture, Facial Skin Pigmentation	09/25	01/26
NCT06747715: Autologous Fresh Fat Grafting Followed by Autologous Cryopreserved Fat Grafting	Not yet recruiting	N/A	22	US	Serial Fat Grafting Fresh followed by Cryopreserved Fat	University of Pittsburgh, Armed Forces Institute of Regenerative Medicine	Facial Defect	12/27	12/27
Shirley, Eleanor
NCT04601532: Superficial Partial-Thickness Burn Study	Terminated	4	26	US	Catasyn™ Advanced Technology Hydrogel and SynePure™ Wound Cleanser, Silver Sulfadiazine, Silvadene Topical Product	J. Peter Rubin, MD, Synedgen, Inc., United States Department of Defense	Superficial Partial Thickness Burn	12/22	12/22
NCT04051242: Enhanced Bioscaffold for Volumetric Muscle Loss	Terminated	N/A	10	US	XenMatrix™ AB Surgical Graft	J. Peter Rubin, MD, United States Department of Defense	Muscle Loss	01/24	01/24
NCT04440189: Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis	Recruiting	N/A	124	US	GID SVF-2 Device System	GID BIO, Inc.	Osteoarthritis, Knee	12/23	12/24
NCT06747715: Autologous Fresh Fat Grafting Followed by Autologous Cryopreserved Fat Grafting	Not yet recruiting	N/A	22	US	Serial Fat Grafting Fresh followed by Cryopreserved Fat	University of Pittsburgh, Armed Forces Institute of Regenerative Medicine	Facial Defect	12/27	12/27